[Some newer findings concerning oxytocin receptor signaling]

V Klenerová1, S Hynie

  • 1Laborator biochemické neurofarmakologie, Ustav lékarské biochemie, 1. lékarská fakulta, Univerzita Karlova, Praha. Vera.Klenerova@LF1.cuni.cz

Ceskoslovenska Fysiologie
|March 28, 2009
PubMed

Insights

Oxytocin (OT) regulates cell growth via its receptor (OTR) by activating different MAP kinase pathways. Understanding these signaling pathways can lead to new therapeutic drugs.

Area of Science:

  • Neuroendocrinology
  • Cellular signaling
  • Pharmacology

Context:

  • Oxytocin (OT) is traditionally known for its roles in uterine contraction and milk ejection.
  • Emerging research highlights OT's diverse regulatory functions in the brain and peripheral tissues, including cell growth.
  • Oxytocin receptors (OTRs) are G-protein coupled receptors (GPCRs) with complex signaling mechanisms.

Purpose:

  • To review the diverse signaling pathways of the oxytocin receptor (OTR).
  • To explore how OTR location within plasma membranes influences signaling.
  • To discuss the role of MAP kinase activation in mediating OT's effects on cell growth.

Summary:

  • OTR signaling is location-dependent, with different membrane localizations triggering distinct pathways.
  • Transient MAP kinase activation stimulates cell growth, while persistent activation inhibits it.
  • OTR signaling involves orthosteric and allosteric receptor activation, MAP kinase cascades, and prostaglandin synthesis.

Impact:

  • Elucidating novel OTR signaling pathways can inform the development of targeted therapies (agonists/antagonists).
  • These findings contribute to a deeper understanding of oxytocin receptor physiology and pharmacology.
  • The study enhances knowledge of GPCR signaling beyond the oxytocin system.

Related Concept Videos

Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...